Surfactant metabolism dysfunction
| Surfactant metabolism dysfunction | |
|---|---|
| Synonyms | Surfactant deficiency disorder |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Respiratory distress, hypoxemia, cyanosis |
| Complications | Respiratory failure, pulmonary hypertension |
| Onset | Neonatal period |
| Duration | Chronic |
| Types | N/A |
| Causes | Genetic mutations in surfactant proteins |
| Risks | Premature birth, family history |
| Diagnosis | Genetic testing, chest X-ray, lung biopsy |
| Differential diagnosis | Neonatal respiratory distress syndrome, bronchopulmonary dysplasia |
| Prevention | N/A |
| Treatment | Surfactant replacement therapy, oxygen therapy, mechanical ventilation |
| Medication | Corticosteroids, antibiotics |
| Prognosis | Variable, depends on severity and treatment |
| Frequency | Rare |
| Deaths | N/A |
Surfactant Metabolism Dysfunction is a genetic disorder that affects the lungs. It is characterized by the inability of the body to produce or process surfactant, a substance that is essential for normal lung function. This disorder can lead to a variety of respiratory problems, including respiratory distress syndrome and interstitial lung disease.
Causes[edit]
Surfactant Metabolism Dysfunction is caused by mutations in certain genes that are involved in the production or processing of surfactant. These genes include ABCA3, SFTPB, SFTPC, and SFTPD. The mutations can be inherited from one or both parents.
Symptoms[edit]
The symptoms of Surfactant Metabolism Dysfunction can vary widely, but they generally include difficulty breathing, cough, and wheezing. In severe cases, the disorder can lead to life-threatening respiratory failure.
Diagnosis[edit]
Diagnosis of Surfactant Metabolism Dysfunction typically involves a combination of medical history, physical examination, and laboratory tests. These tests may include genetic testing to identify mutations in the genes associated with the disorder.
Treatment[edit]
Treatment for Surfactant Metabolism Dysfunction is primarily supportive and aims to manage the symptoms. This may include oxygen therapy, mechanical ventilation, and medications to help improve lung function.
Prognosis[edit]
The prognosis for individuals with Surfactant Metabolism Dysfunction can vary widely. Some individuals may have a relatively mild course of the disease, while others may experience severe respiratory problems that can be life-threatening.
See also[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian